SCHEMBL7130303

SCHEMBL7130303

CC(C)(C)c1cc(C(=O)Nc2ccc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)cc2)cc(C(C)(C)C)c1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.62
RORC P51449 6/20 0.62
MAPT P10636 6/20 0.62
MEN1 O00255 5/20 0.62
SMN1; SMN2 Q16637 5/20 0.62
PPARG P37231 3/20 0.62
CYP3A4 P08684 2/20 0.62
MAPK1 P28482 2/20 0.62
LMNA P02545 1/20 0.62
TP53 P04637 1/20 0.62
CYP1A2 P05177 1/20 0.62
CYP2D6 P10635 1/20 0.62
CYP2C9 P11712 1/20 0.62
PKM P14618 1/20 0.62
TSHR P16473 1/20 0.62
NFKB1 P19838 1/20 0.62
CYP2C19 P33261 1/20 0.62
THPO P40225 1/20 0.62
MTOR P42345 1/20 0.62
PMP22 Q01453 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7120518 0.93 SMN1; SMN2 (0.61) KMT2ARORCMAPTMEN1SMN1; SMN2
SCHEMBL7124272 0.91 RORC (0.64) KMT2ARORCMAPTMEN1SMN1; SMN2
SCHEMBL4322184 0.87 KMT2A (0.57) KMT2AMAPTMEN1SMN1; SMN2MAPK1
SCHEMBL7132322 0.86 KMT2A (0.55) KMT2ARORCMAPTMEN1SMN1; SMN2
SCHEMBL7130609 0.82 RORC (0.84) KMT2ARORCMAPTMEN1SMN1; SMN2
SCHEMBL7120562 0.81 KMT2A (0.82) KMT2ARORCMAPTMEN1SMN1; SMN2
SCHEMBL7125281 0.81 KMT2A (0.78) KMT2ARORCMAPTMEN1SMN1; SMN2
SCHEMBL7119682 0.81 KMT2A (0.69) KMT2ARORCMAPTMEN1SMN1; SMN2
SCHEMBL7119937 0.80 KMT2A (0.72) KMT2ARORCMAPTMEN1SMN1; SMN2
SCHEMBL7129256 0.80 RORC (0.85) KMT2ARORCMAPTMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD KMT2A 3291/4885RORC 67/4885MAPT 4391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.